News for hackers. Stuff that matters.
Re:The EpiPen, a Case Study in Health System Dysfunction by maxerickson on Saturday August 27, 2016 @10:16AM (#12372426)
The market for drugs like that generally functions quite well. Like a cash price of ~$5 a month well.

(The dustup over Martin Shkreli raising the price of Daraprim only happened because there were very few users of the drug)

There are no comments on this comment yet.